Follicular and Hürthle cell carcinoma of the thyroid gland.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Surgical Oncology Clinics of North America

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.SOC.2006.05.011PMID 16882500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hürthle cell tumors: applying molecular markers to define a new management algorithm.

  2006cited by this paper
• Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.

  2006cited by this paper
• Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.

  2005cited by this paper
• Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease.

  2005cited by this paper
• The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma

  2005cited by this paper
• Follicular Thyroid Carcinoma: The Role of Histology and Staging Systems in Predicting Survival

  2005cited by this paper
• What's new in general surgery: endocrine surgery.

  2005cited by this paper
• Circulating tumor cells detected by reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA: distinguishing follicular thyroid carcinoma from adenoma.

  2005cited by this paper
• Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination.

  2005cited by this paper
• The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart.

  2005cited by this paper
• Pathologic Study and Clinical Significance of Hürthle Cell Papillary Thyroid Carcinoma

  2004cited by this paper
• Prognostic Indications for Hürthle Cell Cancer

  2004cited by this paper
• Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer.

  2004cited by this paper
• Molecular analysis of Hurthle cell neoplasms by gene profiling.

  2004cited by this paper
• Follicular thyroid carcinomas with lung metastases: a 23-year retrospective study.

  2004cited by this paper
• A Population-Based Analysis of Survival Factors in Differentiated and Medullary Thyroid Carcinoma

  2003cited by this paper
• 18F-FDG PET of patients with Hürthle cell carcinoma.

  2003cited by this paper
• Prognostic factors in patients with Hürthle cell neoplasms of the thyroid

  2003cited by this paper
• Mutant thyroid hormone receptor beta represses the expression and transcriptional activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis.

  2003cited by this paper
• Survival and prognosis in Hürthle cell carcinoma of the thyroid gland.

  2003cited by this paper
• Follicular thyroid carcinoma

  2002cited by this paper
• Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.

  2002cited by this paper
• Hurthle Cell Neoplasms of the Thyroid

  2002cited by this paper
• Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer

  2002cited by this paper
• Importance of Lymph Node Metastases in Follicular Thyroid Cancer

  2002cited by this paper
• Hürthle cell carcinoma: A 60-year experience

  2002cited by this paper
• Analysis of Tg transcripts by real-time RT-PCR in the blood of thyroid cancer patients.

  2002cited by this paper
• Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment.

  2002cited by this paper
• Testicular dose and fertility in men following I131 therapy for thyroid cancer

  2002cited by this paper
• Isotope imaging for metastatic thyroid cancer.

  2001cited by this paper
• Preoperative Diagnostic Value of [18F] Fluorodeoxyglucose Positron Emission Tomography in Patients With Radioiodine-Negative Recurrent Well-Differentiated Thyroid Carcinoma

  2001cited by this paper
• Serum thyroglobulin measurement. Utility in clinical practice.

  2001cited by this paper
• Serum thyroglobulin measurement. Utility in clinical practice.

  2001cited by this paper
• Reevaluation of the Impact of a Stringent Low-Iodine Diet on Ablation Rates in Radioiodine Treatment of Thyroid Carcinoma

  2001cited by this paper
• Hürthle cell carcinoma

  2001cited by this paper
• Hürthle cell carcinoma: a critical histopathologic appraisal.

  2001cited by this paper
• 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study.

  2001cited by this paper
• Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type

  2001cited by this paper
• Death from thyroid cancer of follicular cell origin.

  2000cited by this paper
• Prognostic factors in patients with differentiated thyroid carcinoma.

  2000cited by this paper
• PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].

  2000cited by this paper
• PAX8-PPARγ1 Fusion in Oncogene Human Thyroid Carcinoma

  2000cited by this paper
• Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?

  2000cited by this paper
• Thyroid carcinoma: diagnostic and therapeutic approach; genetic background (review).

  2000cited by this paper
• Using Recombinant Human TSH in the Management of Well-Differentiated Thyroid Cancer: Current Strategies and Future Directions

  2000cited by this paper
• Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases.

  1999cited by this paper
• Differentiated thyroid cancer: a retrospective analysis of 832 cases from Greece

  1999cited by this paper
• Hürthle cell carcinoma: A malignancy of low‐grade potential

  1999cited by this paper
• The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma

  1998cited by this paper
• A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995

  1998cited by this paper
• Management of follicular and Hürthle cell neoplasms of the thyroid gland.

  1998cited by this paper
• Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy.

  1998cited by this paper
• The dynamics of serum thyroglobulin elimination from the body after thyroid surgery.

  1997cited by this paper
• Hürthle Cell Carcinoma: Total thyroidectomy with central neck lymph node dissection is the therapy of choice for patients with Hürthle cell carcinoma.

  1997cited by this paper
• Differentiated thyroid cancer presenting initially with distant metastasis.

  1997cited by this paper
• Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995.

  1997cited by this paper
• 131I Therapy for Elevated Thyroglobulin Levels

  1997cited by this paper
• Hurthle Cell Carcinoma.

  1997cited by this paper
• Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.

  1996cited by this paper
• The utility of routine frozen section examination for intraoperative diagnosis of thyroid cancer.

  1996cited by this paper
• Surgical considerations and approach to thyroid cancer.

  1996cited by this paper
• Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients.

  1996cited by this paper
• Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid.

  1996cited by this paper
• Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.

  1995cited by this paper
• Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors.

  1995cited by this paper
• Endocrine gland cancer

  1995cited by this paper
• Follicular lesions of the thyroid. Does frozen section evaluation alter operative management?

  1995cited by this paper
• Morbidity and mortality in follicular thyroid cancer.

  1995cited by this paper
• Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.

  1994cited by this paper
• Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

  1994cited by this paper
• The Demise of Follicular Carcinoma of the Thyroid Gland

  1994cited by this paper
• Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy.

  1992cited by this paper
• Oncocytic Neoplasms of the Thyroid Gland

  1992cited by this paper
• Tumors of the thyroid gland

  1992cited by this paper
• Genetic markers in thyroid tumors.

  1991cited by this paper
• Selective postoperative radioactive iodine treatment of thyroid carcinoma

  1990cited by this paper
• Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer.

  1990cited by this paper
• Intraoperative decision making during thyroid surgery based on the results of preoperative needle biopsy and frozen section.

  1990cited by this paper
• Follicular cell predominance in the cytologic examination of dominant thyroid nodules indicates a sixty percent incidence of neoplasia.

  1990cited by this paper
• Flow cytometric DNA measurements in benign and malignant Hürthle cell tumors of the thyroid

  1988cited by this paper
• Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor.

  1988cited by this paper
• Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables.

  1988cited by this paper
• Hurthle cell thyroid tumors. An immunohistochemical study

  1987cited by this paper
• Hurthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy

  1986cited by this paper
• Hürthle cell tumors: a twenty-five-year experience.

  1986cited by this paper
• Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma.

  1986cited by this paper
• Session II: Follicular carcinoma

  1985cited by this paper
• Follicular carcinoma.

  1985cited by this paper
• Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms.

  1985cited by this paper
• Total thyroidectomy for Hürthle cell neoplasm of the thyroid.

  1983cited by this paper
• Oxyphil Tumors of the Thyroid, Follow‐up of 42 Surgical Cases

  1981cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Serum Thyroglobulin Autoantibodies: Prevalence, Influence on Serum Thyroglobulin Measurement, and Prognostic Significance in Patients with Differe

  year unknowncited by this paper

• 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer

  2025cites this paper
• Comparison of Oncocytic and Follicular Carcinoma of the Thyroid Without Initial Distant Metastasis

  2025cites this paper
• Thyroid Cancer: Epidemiology, Classification, Risk Factors, Diagnostic and Prognostic Markers, and Current Treatment Strategies

  2025cites this paper
• Radioactive iodine therapy improves overall survival outcome in oncocytic carcinoma of the thyroid by reducing death risks from noncancer causes: A competing risk analysis of 4641 patients

  2024cites this paper
• Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

  2022cites this paper
• Hürthle Cell Carcinoma: Single Center Analysis and Considerations for Surgical Management Based on the Recent Literature

  2022cites this paper
• Clinicopathological Characteristics and Disease-Free Survival in Patients with Hürthle Cell Carcinoma: A Multicenter Cohort Study in South Korea

  2021cites this paper
• Development and Validation of a Diagnostic Nomogram for the Preoperative Differentiation Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenomas.

  2021cites this paper
• Cancer of the Endocrine System

  2020cites this paper
• Effect of adjuvant radioactive iodine therapy on survival in rare oxyphilic subtype of thyroid cancer (Hürthle cell carcinoma)

  2019cites this paper
• Is Frozen-Section Analysis During Thyroid Operation Useful in the Era of Molecular Testing?

  2019cites this paper
• Neck Ultrasound in Patients with Follicular Thyroid Carcinoma

  2018cites this paper
• Surgery for Thyroid Nodules

  2018cites this paper
• A rare case of sorafenib induced liver injury in a patient with recurrent Hurthle cell carcinoma

  2018influential citation
• Thyroid and Parathyroid Glands

  2017cites this paper
• Follicular and Hürthle Cell Carcinoma

  2017cites this paper
• Radioactive Iodine Treatment Is Associated with Improved Survival for Patients with Hürthle Cell Carcinoma

  2016cites this paper
• Cancer folliculaire oncocytaire de la thyroïde : revue d'une littérature controversée, prédiction du risque métastatique et de la survie dans une série multicentrique de 276 patients du réseau Tuthyref

  2015cites this paper
• Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data

  2014cites this paper
• The Surgical Management of Thyroid Cancer

  2014cites this paper
• NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines

  2014cites this paper
• Clinicopathological and prognostic analysis of follicular thyroid carcinoma in a single institute over a 15-year period.

  2014cites this paper
• New developments in the diagnosis and treatment of thyroid cancer

  2013cites this paper
• The role of ultrasound in the management of nodular thyroid disease and hyperparathyroidism

  2013cites this paper
• Unusual malignant tumors of the thyroid gland.

  2013cites this paper
• Hurthle cell carcinoma

  2013cites this paper
• Malignant Thyroid Conditions

  2012cites this paper
• Ultrasound of the Thyroid and Parathyroid Glands

  2012cites this paper
• Thyroid cancer in older men

  2011cites this paper
• Follicular adenoma and carcinoma of the thyroid gland.

  2011cites this paper
• Hurthle cell neoplasms of thyroid in south-western region of Saudi Arabia.

  2011cites this paper
• Tumeurs atypiques de la thyroïde et formes réfractaires

  2010cites this paper
• Les tumeurs oncocytaires de la thyroide : a propos de 25 cas

  2010cites this paper
• Difficult problems in thyroid cancer surgery.

  2010cites this paper
• Intravascular Metastasis at the Internal Jugular Vein From Follicular Thyroid Carcinoma

  2010cites this paper
• Hür thle Cell Neoplasms of Thyroid in South-Western Region of Saudi Arabia Tumeurs A Cellules De Hürthle De La Glande Thyroïde Dans La Region Du Sud-ouest De L'arabie Saoudite

  2010cites this paper
• Delayed intrathyroidal hematoma causing respiratory distress after a seemingly benign fall: a case report

  2010cites this paper
• Prognostic Factors and Treatment in Follicular Thyroid Carcinoma

  2010cites this paper
• Follicular Thyroid Carcinoma: Clinicopathologic Features, Prognostic Factors, and Treatment Strategy

  2008influential citation
• The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.

  2008cites this paper
• Hurthle Cell Carcinoma of the Thyroid Gland: Clinicopathologic Features and Treatment Outcome Compared with Pure Follicular Thyroid Carcinoma

  2008influential citation
• Cancer of the Endocrine System

  2008cites this paper
• The role of ultrasound in the management of nodular thyroid disease

  2007cites this paper